| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,430,000,000 |
| Market
Cap: |
106.61(B) |
| Last
Volume: |
5,636,901 |
Avg
Vol: |
8,439,653 |
| 52
Week Range: |
$48.64 - $74.55 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 297 |
| Guru Rank Value : 4.1 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
131,028 |
305,705 |
848,086 |
1,903,760 |
| Total Sell Value |
$9,081,880 |
$19,161,337 |
$47,794,933 |
$94,196,882 |
| Total People Sold |
8 |
9 |
11 |
13 |
| Total Sell Transactions |
13 |
23 |
39 |
74 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
• • – |
2022-02-21 |
4 |
D |
$42.55 |
$36,550 |
D/D |
(859) |
140,773 |
|
- |
|
| Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
• • – |
2022-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,804 |
141,632 |
|
- |
|
| Carruthers Wendy |
SVP, Human Resources |
• • – |
2022-02-21 |
4 |
D |
$42.55 |
$19,488 |
D/D |
(458) |
163,562 |
|
- |
|
| Carruthers Wendy |
SVP, Human Resources |
• • – |
2022-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,558 |
164,020 |
|
- |
|
| Mahoney Michael F |
Chairman, President & CEO |
• • – |
2022-02-21 |
4 |
D |
$42.55 |
$317,508 |
D/D |
(7,462) |
2,122,922 |
|
- |
|
| Mahoney Michael F |
Chairman, President & CEO |
• • – |
2022-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,825 |
2,130,384 |
|
- |
|
| Brennan Daniel J. |
EVP and CFO |
• • – |
2022-02-21 |
4 |
D |
$42.55 |
$69,101 |
D/D |
(1,624) |
272,826 |
|
- |
|
| Brennan Daniel J. |
EVP and CFO |
• • – |
2022-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,661 |
274,450 |
|
- |
|
| Nanavaty Maulik |
SVP & Pres, Neuromodulation |
• • – |
2022-02-21 |
4 |
D |
$42.55 |
$25,232 |
D/D |
(593) |
176,192 |
|
- |
|
| Nanavaty Maulik |
SVP & Pres, Neuromodulation |
• • – |
2022-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,714 |
176,785 |
|
- |
|
| Butcher Arthur C |
EVP&Pres, Asia Pacific |
• • – |
2022-02-21 |
4 |
D |
$42.55 |
$30,551 |
D/D |
(718) |
34,248 |
|
- |
|
| Butcher Arthur C |
EVP&Pres, Asia Pacific |
• • – |
2022-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,714 |
34,966 |
|
- |
|
| Monson Jonathan |
VP, Global Controller and CAO |
• • – |
2022-02-21 |
4 |
D |
$42.55 |
$7,659 |
D/D |
(180) |
30,742 |
|
- |
|
| Monson Jonathan |
VP, Global Controller and CAO |
• • – |
2022-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
623 |
30,922 |
|
- |
|
| Eddy Jodi Euerle |
SVP, Chief Info & Digital Off. |
• • – |
2022-02-21 |
4 |
D |
$42.55 |
$11,701 |
D/D |
(275) |
25,035 |
|
- |
|
| Eddy Jodi Euerle |
SVP, Chief Info & Digital Off. |
• • – |
2022-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
935 |
25,310 |
|
- |
|
| Scanlon Meghan |
SVP,Pres,Urology Pelvic Health |
• • – |
2022-02-21 |
4 |
D |
$42.55 |
$9,744 |
D/D |
(229) |
22,286 |
|
- |
|
| Scanlon Meghan |
SVP,Pres,Urology Pelvic Health |
• • – |
2022-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
779 |
22,515 |
|
- |
|
| Carruthers Wendy |
SVP, Human Resources |
• • – |
2022-02-18 |
4 |
D |
$42.55 |
$23,147 |
D/D |
(544) |
162,462 |
|
- |
|
| Carruthers Wendy |
SVP, Human Resources |
• • – |
2022-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,853 |
163,006 |
|
- |
|
| Butcher Arthur C |
EVP&Pres, Asia Pacific |
• • – |
2022-02-18 |
4 |
D |
$42.55 |
$42,210 |
D/D |
(992) |
33,252 |
|
- |
|
| Butcher Arthur C |
EVP&Pres, Asia Pacific |
• • – |
2022-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,372 |
34,244 |
|
- |
|
| Fitzgerald Joseph Michael |
EVP & Pres, Cardiology |
• • – |
2022-02-18 |
4 |
D |
$42.55 |
$77,824 |
D/D |
(1,829) |
214,075 |
|
- |
|
| Fitzgerald Joseph Michael |
EVP & Pres, Cardiology |
• • – |
2022-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,706 |
215,904 |
|
- |
|
| Brown Vance R |
SVP, GC and Corp. Secretary |
• • – |
2022-02-18 |
4 |
D |
$42.55 |
$9,106 |
D/D |
(214) |
31,487 |
|
- |
|
2518 Records found
|
|
Page 19 of 101 |
|
|
0.10 (0.13%) 
